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Transcriptomic Changes Due to Cytoplasmic TDP-43 Expression Revel
Dysregulation of Histone Transcripts and Nuclear Chromatin
Abstract
AR DNA-binding protein 43 (TDP-43) is normally a nuclear RNA-binding protein that exhibits a range of
functions including regulation of alternative splicing, RNA trafficking, and RNA stability. However, in
amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with TDP-43 inclusions (FTLDTDP), TDP-43 is abnormally phosphorylated, ubiquitinated, and cleaved, and is mislocalized to the
cytoplasm where it forms distinctive aggregates. We previously developed a mouse model expressing
human TDP-43 with a mutation in its nuclear localization signal (ΔNLS-hTDP-43) so that the protein
preferentially localizes to the cytoplasm. These mice did not exhibit a significant number of cytoplasmic
aggregates, but did display dramatic changes in gene expression as measured by microarray, suggesting
that cytoplasmic TDP-43 may be associated with a toxic gain-of-function. Here, we analyze new RNAsequencing data from the ΔNLS-hTDP-43 mouse model, together with published RNA-sequencing data
obtained previously from TDP-43 antisense oligonucleotide (ASO) knockdown mice to investigate further
the dysregulation of gene expression in the ΔNLS model. This analysis reveals that the transcriptomic
effects of the overexpression of the ΔNLS-hTDP-43 transgene are likely due to a gain of cytoplasmic
function. Moreover, cytoplasmic TDP-43 expression alters transcripts that regulate chromatin assembly,
the nucleolus, lysosomal function, and histone 3’ untranslated region (UTR) processing. These
transcriptomic alterations correlate with observed histologic abnormalities in heterochromatin structure
and nuclear size in transgenic mouse and human brains.
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TAR DNA-binding protein 43 (TDP-43) is normally a nuclear RNA-binding protein that
exhibits a range of functions including regulation of alternative splicing, RNA trafficking, and
RNA stability. However, in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar
degeneration with TDP-43 inclusions (FTLD-TDP), TDP-43 is abnormally phosphorylated,
ubiquitinated, and cleaved, and is mislocalized to the cytoplasm where it forms distinctive
aggregates. We previously developed a mouse model expressing human TDP-43 with a
mutation in its nuclear localization signal (ΔNLS-hTDP-43) so that the protein preferentially
localizes to the cytoplasm. These mice did not exhibit a significant number of cytoplasmic
aggregates, but did display dramatic changes in gene expression as measured by microarray, suggesting that cytoplasmic TDP-43 may be associated with a toxic gain-of-function.
Here, we analyze new RNA-sequencing data from the ΔNLS-hTDP-43 mouse model,
together with published RNA-sequencing data obtained previously from TDP-43 antisense
oligonucleotide (ASO) knockdown mice to investigate further the dysregulation of gene
expression in the ΔNLS model. This analysis reveals that the transcriptomic effects of the
overexpression of the ΔNLS-hTDP-43 transgene are likely due to a gain of cytoplasmic
function. Moreover, cytoplasmic TDP-43 expression alters transcripts that regulate chromatin assembly, the nucleolus, lysosomal function, and histone 3’ untranslated region (UTR)
processing. These transcriptomic alterations correlate with observed histologic abnormalities in heterochromatin structure and nuclear size in transgenic mouse and human brains.

Introduction
TDP-43 is a member of the heterogeneous ribonuclear protein group and binds to both DNA
and RNA [1,2]. It has a range of functions that affect gene expression including regulation of
transcription, alternative splicing, microRNA biogenesis, and RNA transport and translation
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(reviewed in [3–5]). Under normal physiological conditions, TDP-43 is predominantly localized in the nucleus [6], but is synthesized in the cytoplasm [7] and is shuttled between the
nucleus and cytoplasm in a transcription dependent manner [8]. Several neurodegenerative
diseases display TDP-43 pathology [4], and TDP-43 was identified as the main component of
the distinctive cytoplasmic aggregates seen in ALS and FTLD-TDP [9]. In the pathological
state, TDP-43 is cleared from the nucleus and mislocalized in the cytoplasm or neurites, in
addition to being hyperphosphorylated, ubiquitinated, and cleaved [9–11].
Both a cytoplasmic gain of function and a nuclear loss of function of TDP-43 are possible
disease mechanisms, as neurons with cytoplasmic TDP-43 aggregates are also associated with a
loss of normal nuclear TDP-43 protein [9,12]. We previously [13] developed a tet-off inducible
transgenic mouse overexpressing human TDP-43 (hTDP-43) with a mutated (K82A/R83A/
K84A) nuclear localization signal (ΔNLS-hTDP-43) so that the protein preferentially localizes
to the cytoplasm [7]. Despite the mainly cytoplasmic mislocalization of the hTDP-43 protein
product, these mice did not exhibit a significant number of cytoplasmic aggregates. Interestingly, there was a time-dependent neurodegeneration which coincided with dramatic changes
in gene expression as measured by microarray. An intriguing aspect of the observed gene
expression effects was a selective and significant upregulation of chromatin assembly and histone genes, hinting at a role for TDP-43 in transcription and histone transcript stability.
In this study, we performed RNA-sequencing of ΔNLS-hTDP-43 transgenic mice brains to
further study the transcriptomic effects of the gain of cytoplasmic TDP-43 in this model. This
revealed significant changes in multiple molecular pathways, including confirmation that cytoplasmic TDP-43 expression alters transcription related pathways and histone transcript levels.
Supporting a gain of cytoplasmic function mechanism, biochemical analysis of nuclear and
cytosolic fractions of the ΔNLS-hTDP-43 mice brains showed that total nuclear TDP-43
expression is largely unaltered, suggesting that the exogenous human TDP-43 is able to compensate for autoregulatory reduction of endogenous nuclear mTDP-43. The transcriptomic
changes were compared with RNA sequencing data from mice with reduced levels of TDP-43
after injection with an ASO against TDP-43 [14], revealing a complete absence of correlation
between the two experiments, showing that the main effects of overexpressing ΔNLS-hTDP-43
are likely not due to the loss of TDP-43 function. Furthermore, we identify dysregulation of
the histone 3’ end processing machinery upon transgene overexpression, identifying a mechanism by which overexpression of the ΔNLS-hTDP-43 transgene impairs the transcriptional
machinery.

Materials and Methods
Ethics Statement
Animal care and performed procedures were in accordance with the NIH Guide for the Care
and Use of Experimental Animals and approved by the University of Pennsylvania Institutional Animal Care and Use Committee (Permit Number: 803385).

RNA sequencing of transgenic mice
Inducible transgenic mice overexpressing mutant ΔNLS-hTDP-43 were generated as described
previously [13]. Briefly, a Camk2α promoter was used to drive expression of the tetracycline
transactivator protein (Camk2α-tTa), and a tetracycline responsive promoter was used to drive
ΔNLS-hTDP-43 expression (tetO-ΔNLS-hTDP-43) such that ΔNLS-hTDP-43 protein expression was inhibited by doxycycline in bigenic mice (Camk2a-tTa x tetO-ΔNLS-hTDP-43).
Expression was repressed in bigenic mice (n = 4, 3 male) with a doxycycline diet until 28 days
of age at which time expression was induced by removal of the doxycycline diet. RNA was
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obtained 10 days later because this is when neurodegeneration began in these mice [13]. Nontransgenic mice (n = 4, 3 male) bred from heterozygous parents for Camk2α-tTa and ΔNLShTDP-43 were used as controls, and followed the same diet timeline to control for doxycycline
effects. RNA-seq libraries were constructed and sequenced as previously described [15], with
mean RNA integrity number (RIN) 8.74. After mouse sacrifice, the right cortex was extracted
and solubilized in TRIzol and treated with DNase. Polyadenylated messenger RNA was
selected using the Dynabeads mRNA direct kit (Invitrogen), followed by fragmentation, 5’
phosphate addition, size selection, Illumina v1.5 RNA adapter ligation, cDNA library generation, PCR amplification, and purification before sequencing on an Illumina Genome Analyzer
II. Raw reads and processed data have been deposited in NCBI’s Gene Expression Omnibus
repository [16] and are accessible through GEO Series accession number GSE65973.

Processing of RNA-seq data
Raw reads from both RNAseq experiments had their 3’ Illumina v1.5 smRNA adaptors
(ATCTCGTATGCCGTCTTCTGCTTG) trimmed using cutadapt [17], were mapped to the mm9
Mus musculus genome build using Bowtie (version 0.12.7 with options—time -k 100—best—
strata -v 2 -p 3) [18] and were further filtered to a maximum mismatch rate of 0.06. Only
uniquely mapping reads were considered for further analysis except for histone analysis (see
below). Coverage of the protein-coding segment of the genome was computed using the bedtools coverage [19] tool against the RefSeq mm9 genome, and coverage of the entire genome
was computed using the bedtools genomecov [19] tool. The mapped reads from the RNA
sequencing pipeline were analyzed for differential expression by using bedtools multicov [19]
to compute the number of reads mapping to each exon. Exon counts were merged into gene
counts using bedtools groupBy [19], which were then analyzed for differential expression with
the DESeq2 R package [20]. Splicing analysis was performed using the DEXSeq R package [21]
following the protocol described in the paper and vignette. Briefly, exon reads were counted
using the dexseq_count.py script and read into R [22], where the DEXSeq analysis pipeline was
followed using the Ensembl mm9 genome annotation [23]. For both the differential expression
and the differential splicing analyses, significantly differentially expressed genes/exons were
defined as having an adjusted p-value of less than 0.05 using the Benjamini-Hochberg multiple
testing correction [24].
For pathway analyses, lists of refSeq IDs were obtained through R analysis and uploaded to
NIH DAVID [25,26] for analysis. Background gene lists were the sets of genes meeting the
minimum read count threshold (10 reads per million in at least one sample) in the relevant
experiment being analyzed. From DAVID, lists of gene clusters and gene charts were obtained,
using GOTERM_BP_FAT, GOTERM_CC_FAT, GOTERM_MF_FAT, and KEGG_PATHWAY categories for analysis. To reduce redundancy, these results were passed to a Ruby script,
available from the authors, to group functionally similar pathways together into clusters. From
each cluster of redundant pathways, the pathway with the lowest EASE p-value was selected for
final analysis in R. To compute pathway fold changes, the refSeq IDs of genes in each pathway
were matched with those from the DESeq2 results.
Previously published microarray data [13] is available under GEO accession number
GSE25182. RNA sequencing data was compared with microarray data by finding matching
probes by RefSeq ID.

Analysis of HITS-CLIP data
The processed peaks from the CLIP sequencing data were directly obtained from the authors,
as analyzed in [27]. A custom Python script (genewise_bed_coverage.py) was used to compute
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the number of CLIP hits and proportion of coverage of the CLIP hits over each genetic feature
(introns, exons, 3’ untranslated region, and 5’ untranslated region). This script is available at
https://github.com/alexamlie/bed_statistics.

Bioinformatic Analysis of Histone Transcripts
To account for the fact that histones are grouped in highly repetitive clusters, we remapped
and allowed for up to 10 multimappings for the 50 canonical and variant histone genes of interest, weighting each read as counting for 1/n reads in each of its mapped locations, where n is
the number of times that read mapped. To normalize, we chose 50 random unchanging genes,
defined as having an adjusted DESeq2 p-value of greater than 0.5, and mapped them with up
to 10 multimappings as well. Then, we took the geometric mean of the unchanging gene coverage for each sample, and converted these means into normalization factors by dividing them all
by the mean of the geometric means of the nontransgenic samples. All histone genes with no
coverage were converted to 0.1, the lowest possible coverage, and histone values were divided
by the normalization factors. Finally, we took the separate geometric mean in each sample for
the normalized canonical and variant histone genes. The changes in canonical and variant histones were quantified with 2-sided t-tests between the 4 bigenic and 4 nontransgenic normalized geometric means.

Biochemical Analysis of Nuclear and Cytoplasmic Brain Lysates
Immediately upon sacrifice, cortices from mouse brains were dissected, weighed and frozen at
-80°C. Total vs. nuclear vs. cytosolic fractions were prepared from cortex tissue as follows. Tissue was homogenized using 8 strokes of tight-fitted (B) Dounce homogenizer at 4°C in hypotonic buffer (10 mM KCl, 1.5 mM MgCl2, 1 mM DTT, 10 mM HEPES-KOH, pH 7.4 with
protease inhibitors; 5:1 v/w). After a 10 minute incubation at 4°C, 1.0 M sucrose in hypotonic
buffer (0.36:1 v/w) was added, and samples were Dounce homogenized with an additional 15
strokes. Aliquots were removed as the total fraction. Homogenates were then centrifuged at
1,000xg for 10 minutes at 4°C. 120 μL of the supernatant was taken and spun at 100,000xg for
30 minutes at 4°C. The supernatant from this spin represented the cytosolic fraction. The
remaining supernatant and pellet from the 1,000xg spin were then taken, and 1.77 volumes of
2.3 M sucrose in TKM (50 mM Tris-HCl, pH 7.5, 25 mM KCl, 5 mM MgCl2) was added to
raise the homogenate to 1.6 M sucrose. Additional 1.6M sucrose in TKM was then added to
obtain ~4 mL of homogenate, which was overlaid on 3 mL of 1.8M sucrose in TKM followed
by ultracentrifugation at 100,000xg for one hour at 4°C. The pellets were resuspended in 30 μL
of PBS with protease inhibitors, and nuclei were counted using a hemocytometer. Finally,
based on the nuclei counts, nuclei were diluted in PBS with protease inhibitors so that all samples contained the same concentration of nuclei. Sample buffer was added to all fractions followed by sonication and freezing at -80°C until SDS-PAGE analysis. Equal volumes of lysate
were analyzed by electrophoresis on a 10–17% discontinuous step gradient tris-glycine polyacrylamide gel followed by transfer to nitrocellulose.

Quantitative RT-PCR
RNA was extracted as described previously [13] from the same set of mice that were sequenced.
Additional mice included bigenic mice maintained on doxycycline (n = 5, 2 male) and nontransgenic mice maintained on doxycycline (n = 5, 1 male). cDNA was generated using the
SuperScript III First-Strand Synthesis System (Life Technologies) primed with either random
hexamers or oligo-dTs for total RNA or polyadenylated RNA, respectively. qRT-PCR was performed on the cDNA using an Applied Biosystems 7500 Fast Real-Time PCR system using
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custom-designed primers (see S1 Table for primer sequences) and Power SYBR Green PCR
Master Mix (Life Technologies). Gene expression values were determined by using the comparative CT method. The genes of interest were standardized to the geometric mean of 2 housekeeping genes (Gapdh and Actb).

Immunoblotting
The antibodies used for immunoblotting were rabbit polyclonal C1038 antibody against total
TDP-43 [28], rabbit monoclonal anti histone H3 (Cell Signaling #4499P, Danvers, MA), and
rat monoclonal anti HSP90 (Enzo 16F1, Farmingdale, NY). Immunoblots were visualized
using an Oddysey Sa Infrared Imaging System (LiCor, Lincoln, NE) after application of fluorescent secondary antibodies (LiCor).

Histology
Mouse brains and human brain tissue were fixed and processed into 6 μm sections as previously described [29]. To study nuclear chromatin, sections were stained with cresyl violet using
standard methods. Human tissue sections were stained with anti-TDP-43 antibodies (C1039,
[28]) followed by Alexa568-conjugated secondary antibodies (Life Technologies, Carlsbad,
CA). DAPI was used as a nuclear counterstain. Sections were visualized with a Leica TCS
SPE-II scanning laser confocal microscope to obtain z-stacks through the entire tissue section.
Nuclear cross-sectional area was measured using Leica LAS AF software.

Results
RNA Sequencing of ΔNLS-TDP-43 Mice
To further investigate the widespread transcriptomic changes previously observed by microarray [13], we performed poly(A)+-selected RNA sequencing on right cerebral cortex from
bigenic mice (n = 4, 3 male) and nontransgenic (n = 4, 3 male) control mice. This yielded mean
values of 51,551,711 raw reads and 31,146,050 uniquely mapped reads per sample, with an
average of 1.262x coverage of the protein-coding segment of the genome and 0.496x coverage
of the entire genome. Differentially expressed genes were identified using DESeq2 [20], which
identified 4,321 out of 10,601 genes (Mus musculus mm9 genome annotation) meeting a minimum read threshold of 10 reads per million in at least one sample as being significantly differentially expressed. Of these genes, 2,166 were upregulated in the ΔNLS mice compared to the
control mice, and the remaining 2,155 were downregulated (Fig 1a). By principal component
analysis, the bigenic mice and the nontransgenic mice overall clustered separately, indicating a
robust change in the transcriptome due to overexpression of ΔNLS-hTDP-43 (Fig 1b). Comparison of these results with the previous microarray analysis [13] found that 7,696 of the
10,601 genes meeting the minimum read threshold had matching probes in the microarray,
including just 3,092 of the 4,321 significantly differentially expressed genes, illustrating the
increased sensitivity of RNA sequencing over microarray technology. Of the 3,092 differentially
expressed genes present in the microarray, 2,863 had at least one microarray probe changing in
the same direction as that identified by RNA sequencing, supporting the validity of our RNA
sequencing results.
To identify the effects on biological processes associated with the overexpression of cytoplasmically mislocalized ΔNLS-hTDP-43, pathway analysis was performed on the significantly
up- and down-regulated genes in the bigenic mice as compared to nontransgenic controls
using NIH DAVID [25,26]. This analysis revealed 8 significantly enriched (EASE score Pvalue < 0.001) pathways, 4 of which were up-regulated and 4 of which were down-regulated
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Fig 1. Transcriptomic analysis of ΔNLS-hTDP-43 expressing mice. (A), Comparison of normalized mean
of read counts with log2(fold change) shows no bias for highly expressed genes to be categorized as
differentially expressed. 4,321 out of 10,601 genes meeting the minimum read count threshold were found to
be significantly differentially expressed in ΔNLS-hTDP-43 expressing mice compared to nontransgenic mice
(Benjamini-Hochberg corrected p-value < 0.05, red points). (B), Multidimensional scaling and principal
component analysis shows distinct global transcriptomic profiles for ΔNLS-hTDP-43 bigenic (n = 4) and
control nontransgenic (n = 4) mice. (C), Pathway analysis of significantly changing genes between bigenic
and control mice reveals an upregulation in pathways predominantly involved in nuclear molecular processes
and a downregulation in pathways relating to neuronal or glial function. (D), Splicing analysis reveals that only
23 out of 250,620 exons (red dots) are significantly differentially expressed with Benjamini-Hochberg correct
p-values of less than 0.05.
doi:10.1371/journal.pone.0141836.g001

(Fig 1c). The up-regulated pathways included zinc ion binding, transcription, lytic vacuole, and
nucleolus. Given that the zinc ion pathway contains several zinc finger binding proteins which
are important in regulating transcription, these four pathways largely coincide with pathways
hypothesized to play a central role in ALS and FTLD-TDP, namely RNA regulation and proteostasis [5].
In contrast, the down-regulated pathways, including synaptic transmission, cell-cell adhesion, cell junction, and protein kinase regulator activity, appear to represent processes involved
in more general cellular activity such as cell-cell interactions. Thus, there is a possibility that
these down-regulated pathways may reflect changes secondary to neuronal death and the disruption of neuropil due to reactive gliosis, consistent with the previously described beginnings
of neurodegeneration observed in the ΔNLS-hTDP-43 expressing mice at this timepoint [13].
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Lack of splicing changes in NLS mice
Several reports have implicated TDP-43 in regulation of splicing activity [5,14,30]. To determine whether mice overexpressing ΔNLS-hTDP-43 show splicing changes, we used DEXSeq
[21] to search for differentially spliced exons (Fig 1d). Out of 250,620 exons analyzed, only 23
were identified as differentially spliced (S2 Table). Manual inspection of the 16 unique annotated, non-hypothetical genes in this set revealed that these genes fall into two general categories. Several transcripts regulate transcription and RNA processing, including Srsf5, which is
part of the serine/arginine rich family of proteins that are involved in splicing as well as other
aspects of gene expression [31], Med20, an essential component of the Mediator complex that
regulates transcription [32], and Usp49, a histone H2B deubiquitinase which has been shown
to regulate splicing [33]. Other transcripts are involved in cell signaling and membrane activity,
notably Nrcam, a cell surface molecule that has been associated with autism [34,35]. However,
given that TDP-43 has known effects on RNA splicing within the nucleus, the relative paucity
of splicing alterations observed here suggest that the main transcriptomic effects of ΔNLShTDP-43 overexpression may be due to a gain of cytoplasmic function and not a loss of nuclear
splicing function. Alternatively, TDP-43 has several other RNA functions other than splicing
which were not directly assessed here.

Biochemical analysis of nuclear and cytoplasmic TDP-43 levels
Expression of ΔNLS-hTDP-43 leads to predominantly cytoplasmic transgene expression [7],
and using species-specific TDP-43 antibodies, we have previously shown that ΔNLS-hTDP-43
expression is associated with a reduction of endogenous nuclear mTDP-43 protein [13]. The
relative absence of splicing alterations in ΔNLS-hTDP-43 mice suggests that at least some
TDP-43 protein was present within the nucleus, resulting in functional recovery from the loss
of mTDP-43 in terms of splicing and supporting the idea that the effects of transgene overexpression are mainly due to cytoplasmic gain of function. To biochemically investigate the levels
of TDP-43 protein in ΔNLS-hTDP-43 expressing mice, we performed nuclear and cytosolic
fractionation on neocortex from bigenic (Camk2a-tTa x tetO-ΔNLS-hTDP-43) and non-transgenic or monogenic control mice. Samples were immunoblotted for total (mouse and human)
TDP-43 protein. As expected, the bigenic mice showed increased cytosolic levels of total TDP43 (Fig 2). Moreover, total nuclear TDP-43 protein was slightly higher in ΔNLS-hTDP-43 mice
relative to control mice, suggesting that the exogenous hTDP-43 is indeed able to localize to
the nucleus despite the mutation in the NLS. This slight nuclear increase may also contribute
to toxicity. The lack of histone H3 in the cytosolic fraction and the lack of HSP90 in the nuclear
fraction confirmed successful fractionation. These results demonstrate that ΔNLS-hTDP-43
overexpression leads to a marked increase in cytoplasmic TDP-43 protein with relative preservation of total nuclear TDP-43 protein levels, despite the loss of endogenous mTDP-43. The
increased presence of cytoplasmic TDP-43 protein supports a gain of cytoplasmic function as
one potential mechanism underlying the observed transcriptomic changes, but additional
mechanistic studies to demonstrate this functionally are needed.

Comparison with ASO TDP-43 Knockdown Gene Expression Data
To further characterize the transcriptomic effects specific to the overexpression of ΔNLShTDP-43, we compared our RNA-sequencing results with published RNA-sequencing data
from mice injected with an ASO against TDP-43 which reduces endogenous mTDP-43 protein
levels [14]. While the differentially expressed genes in ΔNLS-hTDP-43 mice seem to be mainly
caused by a cytoplasmic gain of exogenous TDP-43 function as shown by Western blot analysis
and the lack of splicing changes, the differentially expressed genes upon ASO knockdown are
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Fig 2. Nuclear and cytosolic fractionation of ΔNLS-hTDP-43 expressing mice. Subcellular fractionation
followed by immunoblot protein analysis reveals a similar level of nuclear total (human and mouse, h+m)
TDP-43 levels between bigenic (+/+) and control (+/- or -/-) mice, but an increase in cytosolic TDP-43 levels in
the bigenic mice. HSP90 and histone H3 confirms separation of the cytosolic and nuclear fractions,
respectively. n = 4 mice per category (4 bigenic, 2 monogenic, 2 non-transgenic).
doi:10.1371/journal.pone.0141836.g002

more likely to be directly linked to the loss of normal, endogenous TDP-43 protein. Thus, if the
main effects in the ΔNLS-hTDP-43 model are indeed caused by a cytoplasmic gain of function,
comparison of the transcriptomes of these two mouse models should show different effects.
Raw sequencing reads from the ASO experiment (GEO database accession number
GSE27218), were analyzed with the same pipeline used for ΔNLS-hTDP-43 mice. Technical
replicates were combined to analyze biological replicates of control ASO injected mice (n = 4, 4
female) versus TDP-43 ASO injected knockdown mice (n = 4, 4 female). Across these samples,
we found a mean of 30,794,457 total reads, with a mean of 29,132,557 uniquely mapping. We
were able to map more reads than the original study [14], which used an older version of Bowtie (0.12.2) and only uniquely mapped about 50% of total reads, compared to the newer version
we used (0.12.7), reflecting advances in the accuracy of Bowtie. These datasets demonstrated
mean coverage of 1.580x over the protein coding segment of the genome, and a mean coverage
of 0.599x over the entire genome.
We found 11,916 expressed genes in this dataset using the same minimum read count
threshold as earlier. We first compared the expression of the 10,345 genes meeting the minimum read count threshold in both datasets (ΔNLS-hTDP-43 versus ASO) to check whether
the transcriptomic changes due to ΔNLS-hTDP-43 expression versus ASO knockdown of
TDP-43 were generally similar. This analysis demonstrated a complete lack of correlation
between the two sets of mice (Pearson correlation coefficient r = 0.011, Fig 3a).
Next, we compared the differentially expressed genes in the two models. Of the 11,916
genes meeting the minimum read threshold in the ASO dataset, analysis with DESeq2 identified 3,714 as significantly differentially expressed, of which 1,903 were upregulated and 1,811
were downregulated upon TDP-43 ASO knockdown (Fig 3b). Our analysis discovered many
more genes than the 362 upregulated and 239 downregulated found in the original report,
likely due to our improved mapping power as well as the statistical improvements of DESeq2
over the original approach, which used a simple Z score statistic based on the assumption of
reads following a normal distribution to detect differential expression [14,20]. Additionally, in
the original analysis, samples were merged together according to experimental group (control
vs. TDP-43 ASO) before performing differential expression analysis which appeared to result
in a loss of statistical power. However, principal component analysis confirmed the clustering
of samples within knockdown and control conditions, reflecting true transcriptomic changes
due to TDP-43 knockdown (Fig 3c).
Strikingly, although the two datasets shared 10,345 expressed transcripts meeting the minimum read threshold (corresponding to 97.58% of expressed genes in the ΔNLS experiment
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Fig 3. Transcriptomic comparison between ΔNLS-hTDP-43 overexpression and TDP-43 ASO knockdown. (A), Transcriptomic comparison of the
10,345 genes meeting the minimum read count in both experiments shows no correlation between ΔNLS-hTDP expression and TDP-43 ASO knockdown
(Pearson r = 0.011). (B), Differential expression analysis reveals that 3,714 out of 11,916 genes meeting the minimum read count threshold were significantly
differentially expressed (Benjamini-Hochberg corrected p-value < 0.05, red points) upon ASO knockdown, with no bias of read counts on significance. (C),
Multidimensional scaling and principal component analysis shows distinct global transcriptomic profiles for TDP-43 ASO knockdown (n = 4) and control ASO
(n = 4) mice. (D), Comparison of genes meeting the minimum read counts in both experiments shows that although the majority of genes are present in both
experiments, those that are significantly differentially expressed show very little overlap between ΔNLS-hTDP expression and TDP-43 ASO knockdown. (E),
Splicing analysis shows that 1,029 out of 250,620 exons are differentially expressed upon ASO-mediated TDP-43 knockdown. (F), Pathway analysis
suggests that most of the transcriptomic effects due to ASO knockdown are associated with the wound response and neuronal death.
doi:10.1371/journal.pone.0141836.g003

and 86.81% of expressed genes in the ASO experiment), the two experiments revealed vastly
different effects on the expression levels of these transcripts. In fact, only 495 and 202 were significantly down- or up-regulated in both datasets, respectively (Fig 3d). Thus, the effects of
overexpressing ΔNLS-hTDP-43 seem to be distinct from those caused by a direct loss of TDP-

PLOS ONE | DOI:10.1371/journal.pone.0141836 October 28, 2015

9 / 20

Transcriptomic Effects of Cytoplasmic TDP-43

43 function, again suggesting that many of the transcriptomic changes observed in ΔNLShTDP-43 mice may be due to a cytoplasmic gain of TDP-43 function.
We described above that ΔNLS-hTDP-43 mice exhibit a low number of splicing changes.
To demonstrate that this was not due to a lack of power to detect splicing changes in our analysis pipeline, we performed an identical DEXSeq analysis on the RNA sequencing data from the
TDP-43 ASO knockdown experiment. Remarkably, 1,029 out of 250,620 exons were significantly differentially spliced upon ASO knockdown, corresponding to 752 unique genes (Fig
3e). The previously described splicing analysis of this data found 788 genes containing splicing
alterations using a splicing sensitive microarray [27]. Comparison of our results with these
results is not straightforward, as DEXSeq only identifies differential exon usage, while splicing
microarrays assay other classes of splicing events including alternative transcription start sites
and alternative 3’ or 5’ splice sites. In line with this, we found that 115 of the genes we identified
as containing changes in exonic splicing events were present in the splicing microarray results.
It is important to note that transcriptome wide splicing analysis is still difficult, with different
technological platforms and computational methods yielding different results [36]. Despite the
low overlap with the splicing microarray analysis, likely due to these technological differences,
this analysis nevertheless supports the lack of alternative splicing events due to ΔNLS-hTDP43 overexpression. Given that the ΔNLS and ASO experiments had similar numbers of
uniquely mapped reads, the low number of alternative splicing events identified in the ΔNLS
mice does not appear to be due to insufficient read depth or inappropriate choice of methodology. Rather, there appears to be a real paucity of alternative splicing events upon ΔNLS-hTDP43 overexpression, supporting the hypothesis that the main effects of ΔNLS-hTDP-43 are due
to a cytoplasmic gain of function rather than a nuclear loss of function.
Next, to compare the enriched pathways in the two experiments, we performed an identical
pathway analysis procedure on the ASO data. In contrast to the 8 significant pathways identified in the ΔNLS-hTDP-43 experiment, we found 64 significantly enriched pathways among
the differentially expressed genes (EASE score P-value < 0.001, Fig 3f). These pathways appear
to reflect an overall wound response with associated neuronal loss: nearly all of the downregulated pathways represent loss of neuronal function (including synaptic transmission, dendrite,
synaptosome, neurotransmitter transport, synaptic vesicle, microtubule cytoskeleton, and
many more). Additionally, almost all of the upregulated pathways appear to be related to
inflammation and the wound response (including positive regulation of cell death, response to
wounding, regulation of cytokine production, myeloid cell differentiation, T cell proliferation,
and many more). This indicates that the transcriptomic changes seen in ASO mice may reflect
not only the effects of knocking down TDP-43, but also changes due to reaction against the
invasive injection of the antisense oligonucleotide [14].

A Role for TDP-43 in Histone Dysregulation
As chromatin assembly and transcription-related genes were previously found to be dysregulated by microarray [13] and identified again here by RNA sequencing, we sought to further
characterize these pathways by investigating whether TDP-43 regulates histone transcripts. It
is important to note that the RNA sequencing protocol had a polyadenylation selection step.
Histone transcripts can be subdivided into canonical versus variant transcripts: canonical histone transcripts are generally not polyadenylated but rather exhibit a terminal stem-loop structure which is important for their proper trafficking and metabolism. However, misprocessing
of canonical histone transcripts can lead to aberrant polyadenylation [37,38]. In contrast, variant histone transcripts are normally polyadenylated [39].
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We manually generated lists of canonical non-polyadenylated histones as well as histone
variants that are polyadenylated in order to compare the effects of the ΔNLS-hTDP-43 overexpression on these types of histone genes (S3 Table). Out of 34 canonical histone genes and 15
variant histone genes, we only found 5 and 10, respectively, that met the read count threshold
in our DESeq2 analysis. However, because the 3’ ends of many histone mRNAs are identical
and the coding sequence is highly conserved between histone transcripts [40], we reasoned that
the DESeq2 analysis, which used only uniquely mapping reads, was limiting our ability to
quantify the expression of histone transcripts. With this in mind, we allowed reads to multimap
to up to 10 genomic loci within histone genes, weighted by the number of multimappings.
Results were normalized against 50 random unchanging genes (see methods). Indeed, although
some histone genes still had very low coverage, this analysis retrieved additional coverage for
each of the 34 canonical and 15 variant histone genes (S3 Table). Analysis of the difference
between bigenic and nontransgenic control histone gene coverage showed that the canonical
histones were upregulated in the bigenic mice (fold change = 2.12, 2-sided t-test p = 0.046),
while the variant histones were slightly but significantly downregulated in the bigenic mice
(fold change = 0.841, 2-sided t-test p = 0.017) (Fig 4a). Notably, the significant upregulation of
canonical histones in this poly(A)+ selected dataset implies that these transcripts were aberrantly polyadenylated, allowing our protocol to detect them.
To determine whether these changes in canonical histone expression were due to direct
interactions with TDP-43, we used High Throughput Sequencing of RNA isolated by CrossLinking and Immuno-Precipitation (HITS-CLIP) data of TDP-43 RNA binding sites from a
previous study to see whether TDP-43 directly binds to canonical histone transcripts [27].
Analysis of the HITS-CLIP data found that out of 28,661 protein coding genes (mm9 refSeq
mouse genome), 7,697 genes had TDP-43 binding clusters in their exons, introns, 3’ UTRs, or
5’ UTRs. However, only one canonical histone transcript contained any significant TDP-43
binding sites (Hist1h2bc with 2 hits in the 3’ UTR) while three variant histone transcripts contained TDP-43 binding sites (H2afy, H2afy2, and H3f3a), suggesting that the majority of TDP43’s effects on histone transcripts are due to indirect interactions.
We next hypothesized that aberrant polyadenylation of histone transcripts could be due to a
dysregulation of transcripts that regulate histone 3’ UTR processing. We manually generated a
list of such genes involved in histone 3’ UTR processing (Table 1). Analysis of this list showed
that several of these genes were significantly dysregulated in bigenic mice (Fig 4b). These transcripts were also enriched for TDP-43 RNA binding sites from the HITS-CLIP data (Fig 4c),
suggesting a direct role of TDP-43 in regulating these transcripts.
Notably, survival of motor neuron (Smn), another protein implicated in motor neuron
degeneration, is also known to regulate histone 3’ UTR processing [38]. Interestingly, Smn splicing is regulated by TDP-43 [30], and its transcript was significantly downregulated upon ΔNLShTDP-43 expression in our dataset (log2(fold change) = -0.34, adjusted p-value = 0.001034), further supporting the hypothesis that the transgene overexpression leads to aberrant histone 3’
UTR processing.
To validate these changes in histone 3’ UTR processing genes, we performed RT-qPCR on
the same samples used for RNA sequencing to measure canonical histone transcripts (Hist1h4,
Hist1h3), and several transcripts that regulate histone 3’ UTR processing (Snrpd3, Nelfe, Snrpe
and Lsm11). To test whether the observed changes in canonical histones were due to aberrant
polyadenylation, we used both an oligo-dT primer, which selects for polyadenylated RNA transcripts, and random hexamer primers, which have no such selection bias. RT-qPCR measurements using either oligo-dT priming or random hexamer priming validated our RNA-seq data
for transcripts which regulate histone 3’ UTR processing (Fig 4d and 4e). Interestingly, in the
oligo-dT primed experiment, canonical histone genes were significantly upregulated (Hist1h4
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Fig 4. Histone transcript dysregulation in ΔNLS-hTDP-43 mice. (A), Comparison of multimapped read fold change in canonical and variant histones
shows a significant upregulation in canonical histones (fold change = 2.12, 2-sided t-test p = 0.046) and significant but slight downregulation in variant
histones (fold change = 0.841, 2-sided t-test p = 0.017) in transgenic vs nontransgenic mice. (B), Analysis of log2(fold changes) of genes involved in histone
3’ UTR processing reveal an enrichment of significantly changing genes. (C), Analysis of TDP-43 CLIP binding on genes involved in histone 3’ UTR
processing shows enrichment for CLIP binding. (D), RT-qPCR validation of histone 3’ UTR processing genes and canonical histones with an oligo-dT
selection for polyadenylated RNA confirms the upregulation in aberrantly polyadenylated histone genes in the ΔNLS-TDP-43-expressing mice. (E), Similar
RT-qPCR validation with random hexamer priming shows that non-polyadenylated canonical histones are not significantly upregulated in the bigenic mice.
(F), Comparison of RNA-seq and RT-PCR analysis validates RNA-seq results, except for histone transcripts (white filled symbols) which revealed distinct
results when priming with random hexamers versus oligo-dT’s. *p < 0.05, **p < 0.01, *** p < 0.001, **** p < 0.0001.
doi:10.1371/journal.pone.0141836.g004
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Table 1. List of genes involved in histone 3’ UTR processing.
Gene Symbol

Present in DESeq?*

Role

Cpsf2

Yes

Likely to interact with CPSF-73 for cleavage

Cpsf3

Yes

Endonuclease, cleaves histone pre-mRNAs

Eri1

Yes

Aids Slbp in stem loop binding, U7 snRNP stabilization

Lsm10

No

Part of U7 snRNP, process histone mRNA for splicing

Lsm11

Yes

Part of U7 snRNP, process histone mRNA for splicing

Nelfa

Yes

Participates in histone 3’ UTR processing

Nelfb

Yes

Participates in histone 3’ UTR processing

Nelfe

Yes

Participates in histone 3’ UTR processing

Slbp

Yes

Binds stem loop, essential factor

Snrpb

Yes

Part of U7 snRNP, process histone mRNA for splicing

Snrpd3

Yes

Part of U7 snRNP, process histone mRNA for splicing

Snrpe

Yes

Part of U7 snRNP, process histone mRNA for splicing

Snrpf

No

Part of U7 snRNP, process histone mRNA for splicing

Snrpg

No

Part of U7 snRNP, process histone mRNA for splicing

Srrt

Yes

Promotes proper histone 3’ UTR formation

Sympk

Yes

Heat sensitive, essential component of processing machinery

Zfp100

No

Limiting factor in 3’ UTR processing reaction

*Indicates whether this transcript met the minimum threshold count for DESeq2 analysis.
doi:10.1371/journal.pone.0141836.t001

fold change = 2.07, t-test p = 0.0001; Hist1h3 fold change = 1.79, t-test p = 0.00003; Fig 4d),
while the random hexamer primed experiments revealed no upregulation in these genes (Fig
4e). In fact, Hist1h4 was significantly downregulated in the bigenic mice when there was no
poly(A)+ selection step (fold change = 0.74, t-test p = 0.003, Fig 4e). Visualized another way,
comparison of the expression changes based on RNA-seq versus RT-qPCR showed a high correlation with the exception of the random hexamer primed canonical histone genes (Fig 4f,
white boxes). This confirms that ΔNLS-hTDP-43 expression leads to differential expression of
transcripts which regulate histone 3’ UTR processing, coincident with an upregulation in aberrantly polyadenylated canonical histone genes. Additional mechanistic studies are required to
establish a direct link between ΔNLS-hTDP-43 overexpression and the observed histone dysregulation, but these results suggest that this dysregulation may be mediated through changes in
expression of histone 3’ UTR processing genes.
To confirm that these changes were due to transgene overexpression, we performed RTqPCR on four groups of mice: bigenic mice maintained on doxycycline until 28 days of age followed by 10 days off doxycycline, bigenic mice maintained on doxycycline until sacrifice, nontransgenic mice maintained on doxycycline until 28 days of age followed by 10 days off
doxycycline, and nontransgenic mice maintained on doxycycline until sacrifice (Table 2). First,
we confirmed that the levels of polyadenylated histone transcripts (Hist1h3 and Hist1h4, as
determined by calculating the amount of oligo-dT primed histone cDNA normalized by the
amount of random hexamer primed histone cDNA) were no longer altered in transgenic mice
maintained on doxycycline.
We also extended these analyses to measure the transcript levels for 3’UTR processing
genes. The change in Snrpe and Snrpd3 expression observed in bigenic mice off doxycycline
was no longer observed in bigenic mice maintained on doxycycline, and there was a non-significant trend towards the same effect for Lsm11. These results demonstrate that repressing
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Table 2. qPCR validation results for control validation groups. Off-dox refers to mice fed a doxycycline-containing diet until 28 days of age followed by
10 days off doxycycline before sacrifice, while on-dox refers to mice fed a doxycycline-containing diet until sacrifice (n = 4 to 5 per group). Values shown as
mean ± SE. In top two rows (Hist1h3, Hist1h4), values are ratios of oligo-dT:random hexamer-primed expression, and in remaining rows, values are random
hexamer-primed expression values normalized to housekeeping genes.
Bigenic

Non-transgenic

Two-way ANOVA

Post-hoc analysis

Off-dox

On-dox

Off-dox

On-dox

Genotype

Treatment

Interaction

Off-dox

On-dox

Hist1h3

2.11 ± 0.18

1.39 ± 0.33

0.88 ± 0.10

1.10 ± 0.05

0.0020

0.7239

0.0102

***

ns

Hist1h4

1.45 ± 0.05

1.17 ± 0.09

0.93 ± 0.04

1.07 ± 0.04

0.0006

0.6004

0.0071

***

ns

Snrpe

0.79 ± 0.03

1.10 ± 0.05

0.95 ± 0.04

1.04 ± 0.03

0.2326

0.0160

0.0002

*

ns

Lsm11

0.68 ± 0.17

0.93 ± 0.10

0.99 ± 0.06

1.01 ± 0.05

0.0779

0.2068

0.2988

ns

ns

Nelfe

1.03 ± 0.04

1.05 ± 0.04

0.97 ± 0.03

1.02 ± 0.03

0.2879

0.3460

0.6109

ns

ns

Snrpd3

1.28 ± 0.06

1.02 ± 0.06

1.07 ± 0.03

0.94 ± 0.04

0.0127

0.0023

0.2149

*

ns

*p < 0.05,
***p < 0.001.
doi:10.1371/journal.pone.0141836.t002

transgene expression with doxycycline reverses the histone and 3’UTR processing gene dysregulation in bigenic mice.

Alteration of Nuclear Morphology
Given that ΔNLS-hTDP-43 expression leads to dysregulation of transcription, chromatin
assembly, and nucleolar function together with apparent changes in histone transcript processing, we next investigated the effects of ΔNLS-hTDP-43 overexpression on both chromatin and
nucleolar structure. Histological analysis of the ΔNLS-hTDP-43 expressing mouse brain sections stained with cresyl violet revealed widespread nuclear abnormalities (Fig 5a). Normal
pyramidal neurons within the hippocampus demonstrate moderately sized nucleoli together
with several additional foci of heterochromatin (n = 16 nontransgenic or monogenic mice). In
contrast, hippocampal pyramidal neurons from bigenic mice demonstrated markedly enlarged
nucleoli. Moreover, the nuclear chromatin was altered such that there was prominent, densely
packed perinucleolar chromatin and a loss of non-nucleolar heterochromatin. These changes
were accompanied by uniform enlargement of nuclei (i.e. nucleomegaly). These morphologic
changes were seen not only in hippocampal pyramidal neurons, but also in many neuronal
populations which express the TDP-43 transgene in this transgenic model including neocortical neurons, olfactory bulb granular neurons and others (Fig 5a). In contrast, regions devoid of
transgene expression such as the cerebellum did not exhibit histologic evidence of chromatin
abnormalities or nucleomegaly (Fig 5a). These histologic changes were seen in all bigenic mice
in which transgene expression was turned on for 3 months or longer (n = 14, ranging from 3
months to 15 months of transgene expression). In contrast, nuclear changes were subtle or
absent in mice with shorter lengths of transgene expression (n = 21, ranging from 0 to 2
months of transgene expression). Overall, these results corroborate the results of the transcriptomic analysis, supporting a role of cytoplasmic TDP-43 overexpression in chromatin assembly
pathways as well as nucleolar structure and function.
To extend these observed effects on nuclear structure, hippocampal sections from human
cases of FTLD-TDP were immunostained for TDP-43 protein and examined for changes in
nuclear structure. Hippocampal dentate gyrus granular neurons were studied given their uniform size and shape. Although overt chromatin abnormalities were not obvious, nuclei of neurons with cytoplasmic TDP-43 aggregates appeared to be slightly larger than nuclei from
adjacent uninvolved neurons. To verify this finding, the cross-sectional areas of neuronal
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Fig 5. Altered nuclear morphology associated with cytoplasmic TDP-43 protein. (A) Cresyl violet staining of bigenic mice brain sections reveals
abnormal nucleolar and chromatin structure and nucleomegaly affecting hippocampal pyramidal (CA1) neurons, olfactory bulb granular neurons, and
neocortical neurons. Cerebellar granular and Purkinje neurons, where the transgene is not expressed, show no nuclear morphologic change. (B)
Representative confocal immunofluorescence image of human hippocampal dentate gyrus neuronal nuclei stained with DAPI (blue) with and without TDP-43
inclusions (red). (C) Quantification of average cross sectional nuclear area of neurons without TDP-43 inclusions (n = 254) and neurons with TDP-43
inclusions (n = 133) from 13 different FTLD-TDP cases. Median value of nuclear area for neurons without TDP-43 inclusions is 57.56 μm2 and is 75.66 μm2
for neurons with TDP-43 inclusions. Paired t-test reveals a significant difference in nuclear size (p < 0.0001).
doi:10.1371/journal.pone.0141836.g005

nuclei with and without TDP-43 inclusions were measured from three-dimensional confocal
microscopy image stacks. 133 nuclei associated with TDP-43 inclusions and 254 adjacent uninvolved nuclei were measured from 13 human cases which revealed that nuclei of neurons with
cytoplasmic TDP-43 aggregates had a 31.4% larger cross-sectional area (75.66 μm2) relative to
nuclei of adjacent uninvolved neurons (57.56 μm2) (Fig 5b). Comparing the average cross sectional area of nuclei from neurons with inclusions against those without by case showed that
this difference was significant (paired t-test p < 0.0001, Fig 5c). Thus, nucleomegaly is a feature
of both experimental models of TDP-43 proteinopathy and human disease neurons.

Discussion
The integrative analysis of the molecular phenotype of the ΔNLS-hTDP-43 expressing mouse
performed in this study revealed varied effects of the cytoplasmic overexpression of TDP-43.
Transcriptomic analysis using RNA sequencing technology revealed broad effects of the
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transgene overexpression, including upregulation of genes related to transcription, chromatin
assembly, the nucleolus and protein metabolism, as well as downregulation of genes related to
synaptic activity and posttranslational modification. We identified specific dysregulation in
histone 3’ UTR processing genes due to cytoplasmic TDP-43 overexpression, coincident with
the surprising overrepresentation of canonical histone transcripts in the poly(A)+ selected
RNA sequencing data and elucidating a specific role for TDP-43 in the previously reported
dysfunction of the chromatin assembly pathway [13]. Defects in chromatin assembly and the
nucleolus were also confirmed histologically where abnormal patterns of chromatin staining
and nucleomegaly were observed. Importantly, these abnormal patterns were identified in both
the experimental mouse model as well as in human FTD-TDP patients, suggesting that the
transcriptomic changes underlying these chromatin assembly defects may also be relevant to
the disease in humans. Nucleomegaly has not been well studied in neurodegenerative diseases,
but it has been observed in asymptomatic Alzheimer’s disease patients [41].
In the broader context of TDP-43 biology, this analysis suggests that a gain of cytoplasmic
TDP-43 function affects nuclear dynamics. Specifically, the presence of increased cytoplasmic
levels of TDP-43 protein leads to aberrations in histone 3’ UTR processing gene transcription,
resulting in defects in histone processing such as irregular polyadenylation that contribute to
defects in the chromatin assembly process. Several lines of evidence support this claim, including the presence of aberrantly polyadenylated canonical histone transcripts in the RNA
sequencing data, PCR validation of increases in polyadenylated canonical histones, and histological validation of defects in chromatin assembly.
Although we had previously hypothesized that the toxic effects of the ΔNLS-hTDP-43 overexpression were caused by dysregulation of endogenous mTDP-43, therefore mainly representing a loss of function [13], our comparison with the ASO TDP-43 knockdown experiment
showed that, at least on the transcriptomic level, mice expressing ΔNLS-hTDP-43 show little
evidence of a pure loss of function. It is clear from our previous study that the endogenous
nuclear mTDP-43 levels are reduced following ΔNLS-hTDP-43 expression, but hTDP-43 was
also shown to be present at significant levels in the nucleus [13]. Our fractionation protocol
confirmed that the levels of total (mouse and human) TDP-43 protein were similar in nuclei of
both bigenic and nontransgenic mice, suggesting that despite the introduction of a mutation
within the nuclear localization signal, the transgene is able to generate enough nuclear hTDP43 protein to compensate for the downregulation in mTDP-43 expression.
The lack of transcriptomic similarity with the ASO knockdown, the unchanged level of
nuclear total TDP-43 protein, and the marked increase in cytoplasmic TDP-43 protein levels
altogether suggest that the widespread degeneration and transcriptomic changes observed in
the ΔNLS-hTDP-43 expressing mice may be mainly due to a toxic gain of cytoplasmic TDP-43
function. This is further supported by the paucity of splicing changes upon expression of
ΔNLS-hTDP-43, implying that the exogenous hTDP-43 seems to be able to mostly compensate
for the disruption of endogenous mTDP-43 nuclear splicing regulatory activity. It is important
to note that cytoplasmic TDP-43 inclusions are very rare in these mice, suggesting that the
effects observed in this model seem to be due specifically to a gain of cytoplasmic function as
opposed to toxic aggregation. Furthermore, comparison of the transcriptomic results with
HITS-CLIP data of TDP-43 RNA binding partners showed that six out of the eight significantly
changing pathways were significantly enriched for TDP-43 binding targets (data not shown).
This suggests that many of the transcriptomic effects in these mice involve the direct interactions of TDP-43 with its RNA targets, as opposed to indirect effects arising from the cytoplasmic mislocalization.
This analysis also confirmed our previous report of ΔNLS-hTDP-43 affecting chromatin
assembly genes. Our RNA-seq, HITS-CLIP and RT-PCR analyses showed that TDP-43
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interacts with and alters the expression of several transcripts involved in histone 3’ UTR processing, suggesting that canonical histone dysregulation may be a mechanism by which chromatin assembly pathways and nuclear dynamics are disrupted. These transcriptomic results
were supported by our histological findings which showed irregular chromatin structure in
neurons expressing ΔNLS-hTDP-43.
Aberrant histone transcript polyadenylation has been shown to affect translation of histone
transcripts. Knockdown of stem loop binding protein, the protein that binds the stem loop of
histones and facilitates proper histone transcript processing and trafficking, leads to aberrantly
polyadenylated histone transcripts which are retained in the nucleus and therefore not translated [42]. However, another study suggested that polyadenylated histone transcripts can be
transported to the cytoplasm, bound to polyribosomes, and translated [43]. Furthermore, as
histone translation is highly dependent on cell cycle stage [39], the regulation of histone transcripts in non-dividing neurons is not well understood. We did not detect a change in the levels
of histone protein H3 in bigenic mice compared to nontransgenic controls at steady state (Fig
2). Given the strong physical association between histone proteins and chromatin, a reduction
in histone protein synthesis may not lead to changes in steady state histone levels but rather
could lead to more subtle changes in histone turnover or flux. Another layer of complexity is
that independent of any effects on translation, the degradation of these histone transcripts,
which is also cell cycle dependent [39], may also be affected by aberrant polyadenylation.
Together, this study further supports the importance of the role of TDP-43 in transcriptional regulation and identifies a specific effect of the overexpression of cytoplasmic TDP-43
on nuclear dynamics and misprocessing of the 3’ end of histone transcripts. Although this
model artificially induces a gain of cytoplasmic function, the results observed here provide an
insight into the consequences of pathological cytoplasmic accumulation of TDP-43. The question of whether the pathological effects of TDP-43 in ALS and FTLD-TDP are caused by a
nuclear loss of function or a cytoplasmic gain of function is still uncertain [44], but this study
provides an improved understanding of the effects of a cytoplasmic gain of function. The mice
expressing the ΔNLS-hTDP-43 transgene suffered neurodegeneration without common cytoplasmic TDP-43 aggregations [13], suggesting that the mechanisms identified in this study
may play an important role in the pathological process even without the development of TDP43 inclusions, perhaps modeling a pre-aggregated disease state.
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Ensembl mm9 genome annotation [23].
(XLSX)
S2 Table. RT-qPCR Primer Sequences.
(XLSX)
S3 Table. Canonical and variant histone genes in the multimapping analysis. Entries with
the same gene cluster entry represent different members of highly similar clusters. Type
c = canonical, v = variant.
(XLSX)

Acknowledgments
We gratefuly acknowledge Maribel Patino for technical assistance.

PLOS ONE | DOI:10.1371/journal.pone.0141836 October 28, 2015

17 / 20

Transcriptomic Effects of Cytoplasmic TDP-43

Author Contributions
Conceived and designed the experiments: EBL LSW VML JQT LKK AAW. Performed the
experiments: AAW YX ES ID. Analyzed the data: AAW PR RT EBL. Contributed reagents/
materials/analysis tools: BDG VVD JQT VML EBL. Wrote the paper: AAW EBL LSW LKK
VML JQT.

References
1.

Ou S, Wu F, Harrich D, García-Martínez L, Gaynor R. Cloning and characterization of a novel cellular
protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs. J
Virol. 1995;

2.

Buratti E, Baralle FE. Characterization and functional implications of the RNA binding properties of
nuclear factor TDP-43, a novel splicing regulator of CFTR exon 9. J Biol Chem. 2001 Sep 28; 276
(39):36337–43. PMID: 11470789

3.

Lagier-Tourenne C, Polymenidou M, Cleveland DW. TDP-43 and FUS/TLS: emerging roles in RNA
processing and neurodegeneration. Hum Mol Genet. 2010 Apr 15; 19(R1):R46–64. doi: 10.1093/hmg/
ddq137 PMID: 20400460

4.

Chen-Plotkin AS, Lee VM-Y, Trojanowski JQ. TAR DNA-binding protein 43 in neurodegenerative disease. Nat Rev Neurol. 2010 Mar; 6(4):211–20. doi: 10.1038/nrneurol.2010.18 PMID: 20234357

5.

Ling S-C, Polymenidou M, Cleveland DW. Converging mechanisms in ALS and FTD: disrupted RNA
and protein homeostasis. Neuron. Elsevier Inc.; 2013 Aug 7; 79(3):416–38.

6.

Wang I, Reddy NM, Shen C-KJ. Higher order arrangement of the eukaryotic nuclear bodies. Proc Natl
Acad Sci. 2002 Oct 15; 99(21):13583–8. PMID: 12361981

7.

Winton MJ, Igaz LM, Wong MM, Kwong LK, Trojanowski JQ, Lee VM-Y. Disturbance of nuclear and
cytoplasmic TAR DNA-binding protein (TDP-43) induces disease-like redistribution, sequestration, and
aggregate formation. J Biol Chem. 2008 May 9; 283(19):13302–9. doi: 10.1074/jbc.M800342200
PMID: 18305110

8.

Ayala YM, Zago P, D’Ambrogio A, Xu Y-F, Petrucelli L, Buratti E, et al. Structural determinants of the
cellular localization and shuttling of TDP-43. J Cell Sci. 2008 Nov 15; 121(Pt 22):3778–85. doi: 10.
1242/jcs.038950 PMID: 18957508

9.

Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, et al. Ubiquitinated TDP-43
in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science (80-). 2006 Oct 6; 314
(5796):130–3.

10.

Buratti E, Baralle FE. Multiple roles of TDP-43 in gene expression, splicing regulation, and human disease. Front Biosci. 2008 Jan; 13:867–78. PMID: 17981595

11.

Kwong LK, Neumann M, Sampathu DM, Lee VM-Y, Trojanowski JQ. TDP-43 proteinopathy: the neuropathology underlying major forms of sporadic and familial frontotemporal lobar degeneration and motor
neuron disease. Acta Neuropathol. 2007 Jul; 114(1):63–70. PMID: 17492294

12.

Cairns NJ, Neumann M, Bigio EH, Holm IE, Troost D, Hatanpaa KJ, et al. TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions. Am J Pathol. American Society for
Investigative Pathology; 2007 Jul; 171(1):227–40.

13.

Igaz LM, Kwong LK, Lee EB, Chen-plotkin A, Swanson E, Unger T, et al. Dysregulation of the ALSassociated gene TDP-43 leads to neuronal death and degeneration in mice. J Clin Invest. 2011; 121
(2).

14.

Polymenidou M, Lagier-Tourenne C, Hutt KR, Huelga SC, Moran J, Liang TY, et al. Long pre-mRNA
depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nat Neurosci.
2011 Feb; 14(4):459–68. doi: 10.1038/nn.2779 PMID: 21358643

15.

Elliott R, Li F, Dragomir I, Chua MMW, Gregory BD, Weiss SR. Analysis of the host transcriptome from
demyelinating spinal cord of murine coronavirus-infected mice. PLoS One. 2013 Jan; 8(9):e75346. doi:
10.1371/journal.pone.0075346 PMID: 24058676

16.

Edgar R, Domrachev M, Lash AE. Gene Expression Omnibus: NCBI gene expression and hybridization
array data repository. Nucleic Acids Res. 2002; 30(1):207–10. PMID: 11752295

17.

Martin M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet.journal. 2011; 17:10–2.

18.

Langmead B, Trapnell C, Pop M, Salzberg SL. Ultrafast and memory-efficient alignment of short DNA
sequences to the human genome. Genome Biol. 2009 Jan; 10(3):R25. doi: 10.1186/gb-2009-10-3-r25
PMID: 19261174

PLOS ONE | DOI:10.1371/journal.pone.0141836 October 28, 2015

18 / 20

Transcriptomic Effects of Cytoplasmic TDP-43

19.

Quinlan AR, Hall IM. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics. 2010 Mar 15; 26(6):841–2. doi: 10.1093/bioinformatics/btq033 PMID: 20110278

20.

Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data
with DESeq2. Genome Biol. 2014 Dec 5; 15(12):550. PMID: 25516281

21.

Anders S, Reyes A, Huber W. Detecting differential usage of exons from RNA-seq data. Genome Res.
2012 Oct; 22(10):2008–17. doi: 10.1101/gr.133744.111 PMID: 22722343

22.

R Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria; 2014.

23.

Cunningham F, Amode MR, Barrell D, Beal K, Billis K, Brent S, et al. Ensembl 2015. Nucleic Acids Res.
2014; 43(D1):D662–9.

24.

Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to
multiple testing. J R Stat Soc Ser B (Statistical Methodol. 1995;

25.

Huang DW, Sherman BT, Lempicki R a. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009 Jan; 37(1):1–13. doi: 10.1093/nar/
gkn923 PMID: 19033363

26.

Huang DW, Sherman BT, Lempicki R a. Systematic and integrative analysis of large gene lists using
DAVID bioinformatics resources. Nat Protoc. 2009 Jan; 4(1):44–57. doi: 10.1038/nprot.2008.211
PMID: 19131956

27.

Lagier-Tourenne C, Polymenidou M, Hutt KR, Vu AQ, Baughn M, Huelga SC, et al. Divergent roles of
ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs. Nat Neurosci.
Nature Publishing Group; 2012 Nov; 15(11):1488–97.

28.

Igaz LM, Kwong LK, Xu Y, Truax AC, Uryu K, Neumann M, et al. Enrichment of C-terminal fragments in
TAR DNA-binding protein-43 cytoplasmic inclusions in brain but not in spinal cord of frontotemporal
lobar degeneration and amyotrophic lateral sclerosis. Am J Pathol. American Society for Investigative
Pathology; 2008 Jul; 173(1):182–94.

29.

Lee EB, Zhang B, Liu K, Greenbaum E a, Doms RW, Trojanowski JQ, et al. BACE overexpression
alters the subcellular processing of APP and inhibits Abeta deposition in vivo. J Cell Biol. 2005 Jan 17;
168(2):291–302. PMID: 15642747

30.

Bose JK, Wang I-F, Hung L, Tarn W-Y, Shen C-KJ. TDP-43 overexpression enhances exon 7 inclusion
during the survival of motor neuron pre-mRNA splicing. J Biol Chem. 2008 Oct 24; 283(43):28852–9.
doi: 10.1074/jbc.M805376200 PMID: 18703504

31.

Manley J, Krainer A. A rational nomenclature for serine/arginine-rich protein splicing factors (SR proteins). Genes Dev. 2010;1073–4. doi: 10.1101/gad.1934910 PMID: 20516191

32.

Larivière L, Geiger S, Hoeppner S, Röther S, Strässer K, Cramer P. Structure and TBP binding of the
Mediator head subcomplex Med8-Med18-Med20. Nat Struct Mol Biol. 2006 Oct; 13(10):895–901.
PMID: 16964259

33.

Zhang Z, Jones A, Joo H-Y, Zhou D, Cao Y, Chen S, et al. USP49 deubiquitinates histone H2B and regulates cotranscriptional pre-mRNA splicing. Genes Dev. 2013 Jul 15; 27(14):1581–95. doi: 10.1101/
gad.211037.112 PMID: 23824326

34.

Marui T, Funatogawa I, Koishi S, Yamamoto K, Matsumoto H, Hashimoto O, et al. Association of the
neuronal cell adhesion molecule (NRCAM) gene variants with autism. Int J Neuropsychopharmacol.
2009; 12:1–10. doi: 10.1017/S1461145708009127 PMID: 18664314

35.

Lane RP, Chen XN, Yamakawa K, Vielmetter J, Korenberg JR, Dreyer WJ. Characterization of a highly
conserved human homolog to the chicken neural cell surface protein Bravo/Nr-CAM that maps to chromosome band 7q31. Genomics. 1996 Aug 1; 35(3):456–65. PMID: 8812479

36.

Liu R, Loraine AE, Dickerson JA. Comparisons of computational methods for differential alternative
splicing detection using RNA-seq in plant systems. BMC Bioinformatics. 2014;1–16.

37.

Narita T, Yung TMC, Yamamoto J, Tsuboi Y, Tanabe H, Tanaka K, et al. NELF interacts with CBC and
participates in 3’ end processing of replication-dependent histone mRNAs. Mol Cell. 2007 May 11; 26
(3):349–65. PMID: 17499042

38.

Tisdale S, Lotti F, Saieva L, Van Meerbeke JP, Crawford TO, Sumner CJ, et al. SMN is essential for the
biogenesis of U7 small nuclear ribonucleoprotein and 3’-end formation of histone mRNAs. Cell Rep.
The Authors; 2013 Dec 12; 5(5):1187–95.

39.

Marzluff WF, Wagner EJ, Duronio RJ. Metabolism and regulation of canonical histone mRNAs:
life without a poly(A) tail. Nat Rev Genet. 2008 Nov; 9(11):843–54. doi: 10.1038/nrg2438 PMID:
18927579

40.

Marzluff WF, Gongidi P, Woods KR, Jin J, Maltais LJ. The Human and Mouse Replication-Dependent
Histone Genes. Genomics. 2002 Nov; 80(5):487–98. PMID: 12408966

PLOS ONE | DOI:10.1371/journal.pone.0141836 October 28, 2015

19 / 20

Transcriptomic Effects of Cytoplasmic TDP-43

41.

Riudavets MA, Iacono D, Resnick SM, O’Brien R, Zonderman AB, Martin LJ, et al. Resistance to Alzheimer’s pathology is associated with nuclear hypertrophy in neurons. Neurobiol Aging. 2007; 28
(10):1484–92. PMID: 17599696

42.

Sullivan KD, Mullen TE, Marzluff WF, Wagner EJ. Knockdown of SLBP results in nuclear retention of
histone mRNA. RNA. 2009 Mar; 15(3):459–72. doi: 10.1261/rna.1205409 PMID: 19155325

43.

Kari V, Karpiuk O, Tieg B, Kriegs M, Dikomey E, Krebber H, et al. A subset of histone H2B genes produces polyadenylated mRNAs under a variety of cellular conditions. PLoS One. 2013 Jan; 8(5):
e63745. doi: 10.1371/journal.pone.0063745 PMID: 23717473

44.

Lee EB, Lee VM-Y, Trojanowski JQ. Gains or losses: molecular mechanisms of TDP43-mediated neurodegeneration. Nat Rev Neurosci. Nature Publishing Group; 2012 Jan; 13(1):38–50.

PLOS ONE | DOI:10.1371/journal.pone.0141836 October 28, 2015

20 / 20

